Skip to main content
ETON
NASDAQ Life Sciences

Eton 10-Q: Q3 Sales $57.9M, Nine-Month Operating Cash Flow $49.9M, Cash Builds to $55.6M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$57.902
Mkt Cap
$1.348B
52W Low
$14.27
52W High
$66.37
52W Position info
306% above low
Off High info
13% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

ETON has more than doubled off its 52-week low of $14.27.

Summary

Eton's Q3 10-Q confirms $57.9 million of product sales, $49.9 million of nine-month operating cash flow and $55.6 million of cash, with net income boosted by a $12.9 million non-cash tax valuation allowance release.


Key Events · Earnings and Guidance · ETON

  • Q3 Product Sales $57.9M, Up 158%

    Third-quarter net product sales were $57,925 thousand versus $22,459 thousand a year earlier, driven by the February 2026 HEMANGEOL acquisition and growth across INCRELEX, ALKINDI SPRINKLE, KHINDIVI, GALZIN, DESMODA and Carglumic Acid.

  • Nine-Month Operating Cash Flow $49.9M

    Net cash from operating activities reached $49,901 thousand for the nine months versus $22,075 thousand in 2025, funding $18,225 thousand of product license purchases and $8,000 thousand of debt repayment while cash rose to $55,628 thousand.

  • Net Income Inflated by Tax Benefit

    Q3 net income of $35,249 thousand includes a $12,892 thousand non-cash release of a deferred tax valuation allowance; non-GAAP diluted EPS was $0.50 versus GAAP diluted EPS of $1.06.

  • Debt Cut to $23.1M Net

    The SWK/Runway facility was reduced by $8,000 thousand of principal payments including a $5,000 thousand prepayment; $3,000 thousand quarterly principal payments begin November 2026 with $7,000 thousand due at December 2027 maturity.


Analysis · ETON · Life Sciences

The headline numbers were already out this evening via the 8-K, but the 10-Q is where the balance sheet and cash generation become verifiable. Nine-month operating cash flow of $49.9 million against $22.1 million a year earlier, plus $55.6 million of cash after $18.2 million of product-rights purchases and $8.0 million of debt repayment, shows the business now funds its own deal-making. The $35.2 million Q3 net income is flattered by a $12.9 million non-cash release of a deferred tax valuation allowance; non-GAAP diluted EPS was $0.50. Watch the $3,000 thousand quarterly principal payments starting November 2026 and the $10 million LIBERVANT upfront paid in October, which will draw on that cash in Q4.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ETON was trading at $57.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $14.27 to $66.37. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ETON - Latest Insights

ETON
Nov 06, 2026, 9:04 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $58.86
Real-time Price: $60.85 info
Change: +$1.99 (+3%) info
Market Cap: $1.755B info
ETON
Nov 05, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $56.06
Real-time Price: $60.85 info
Change: +$4.79 (+9%) info
Market Cap: $1.755B info
ETON
Nov 05, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $47.15
Real-time Price: $60.85 info
Change: +$13.70 (+29%) info
Market Cap: $1.755B info
ETON
Nov 05, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $47.15
Real-time Price: $60.85 info
Change: +$13.70 (+29%) info
Market Cap: $1.755B info
ETON
Nov 05, 2026, 4:01 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $58.85
Real-time Price: $60.85 info
Change: +$2.00 (+3%) info
Market Cap: $1.755B info